PQE Group is proud to announce that, for the fifth consecutive year, its US subsidiary has been…
The Brain Canada Foundation and CQDM are launching a joint call to support…
Quantum Leap supports SMEs and universities in carrying out translational…
SynergiQc, our biopharmaceutical R&D funding program, is designed to support …
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disease affecting…
Université Laval and Glycovax Pharma announce an exclusive global license agreement granting…
In an industry where everything moves both quickly and slowly at the same time, one thing remains…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy